Seres Therapeutics (MCRB) Capital Expenditures (2014 - 2025)
Seres Therapeutics' Capital Expenditures came in at $29,000 for Q4 2025, down 67.8% from $90,000 a year earlier but up 262.5% from the prior quarter.
Analysis
Seres Therapeutics (MCRB) Capital Expenditures (2014 - 2025) Analysis & Trends
For FY2025, Seres Therapeutics' Capital Expenditures was $252,000, down 33.7% from FY2024.
- Capital Expenditures has declined in each of the last three years, with a five-year compound annual growth rate of -15.7% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $380,000 in FY2024 (-95.2%), $7.98 million in FY2023 (-18.8%), $9.82 million in FY2022 (+2.7%) and $9.57 million in FY2021.
- The five-year range for quarterly Capital Expenditures is $8,000 (Q3 2025) to $4.09 million (Q3 2021).
- Year-over-year, Capital Expenditures increased in 1 of the last eight quarters, with an average decline of 62.1%.
- The fastest year-over-year change in Capital Expenditures over five years came in Q4 2021 (growth of 598.2%), and the weakest in Q1 2024 (a decline of 98.5%).
- Business Quant data shows MCRB's Capital Expenditures at $8,000 (Q3 2025), $181,000 (Q2 2025) and $34,000 (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Seres Therapeutics | 22.42 Mn | -116.41 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 29,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 181,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Dec 31, 2024 | 90,000.00 |
| Sep 30, 2024 | 129,000.00 |
| Jun 30, 2024 | 99,000.00 |
| Mar 31, 2024 | 62,000.00 |
| Dec 31, 2023 | 877,000.00 |
| Sep 30, 2023 | 1.80 Mn |
| Jun 30, 2023 | 1.23 Mn |
| Mar 31, 2023 | 4.07 Mn |
| Dec 31, 2022 | 3.46 Mn |
| Sep 30, 2022 | 1.25 Mn |
| Jun 30, 2022 | 2.16 Mn |
| Mar 31, 2022 | 2.95 Mn |
| Dec 31, 2021 | 1.58 Mn |
| Sep 30, 2021 | 4.09 Mn |
| Jun 30, 2021 | 2.55 Mn |
| Mar 31, 2021 | 1.34 Mn |
API Access
Seres Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=MCRB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "MCRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=MCRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();